We are live on
!
Find out more
JG
Jain Global Portfolio holdings
AUM
$24.2B
1-Year Est. Return
34.82%
This Fund
S&P 500
This Quarter
Est. Return
+11.86%
1 Year Est. Return
+34.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.9B
AUM Growth
+$4.5B
(+54%)
Cap. Flow
+$3.27B
Cap. Flow
% of AUM
25.4%
Top 10 Holdings %
Top 10 Hldgs %
34.34%
Holding
1,700
New
646
Increased
290
Reduced
172
Closed
568
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$74.9M |
| 3 |
American Tower
AMT
|
+$74.5M |
| 4 |
Ecolab
ECL
|
+$71.2M |
| 5 |
Tesla
TSLA
|
+$69.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.3B |
| 2 |
Microsoft
MSFT
|
+$64.2M |
| 3 |
NVIDIA
NVDA
|
+$58.5M |
| 4 |
PPG Industries
PPG
|
+$47.7M |
| 5 |
Boeing
BA
|
+$41.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.12% |
| 2 | Industrials | 6.77% |
| 3 | Consumer Discretionary | 5.95% |
| 4 | Financials | 5.42% |
| 5 | Healthcare | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
DocGo
DCGO
$58.9M
| $67.8K | ﹤0.01% |
+43,175
| New | +$80.5K |
|
1052
Jasper Therapeutics
JSPR
$22.9M
| $67.3K | ﹤0.01% |
+12,130
| New | +$59.7K |
|
1053
BRC Group Holdings
RILY
$277M
| $67.1K | ﹤0.01% |
+22,602
| New | +$69.4K |
|
1054
ProKidney
PROK
$308M
| $66.6K | ﹤0.01% |
+112,406
| New | +$87.5K |
|
|
ILPT
1055
Industrial Logistics Properties Trust
ILPT
$613M
| $65.9K | ﹤0.01% |
+14,475
| New | +$47.9K |
|
1056
Orchestra BioMed
OBIO
$224M
| $65.6K | ﹤0.01% |
+24,462
| New | +$71.4K |
|
|
QIPT
1057
DELISTED
Quipt Home Medical
QIPT
| $65.4K | ﹤0.01% |
+36,554
| New | +$72.1K |
|
1058
Biomea Fusion
BMEA
$90.4M
| $63.6K | ﹤0.01% |
+35,360
| New | +$68.1K |
|
1059
Newell Brands
NWL
$2.16B
| $63K | ﹤0.01% |
11,666
-20,562
| -64% | -$109K |
|
1060
Aura Biosciences
AURA
$729M
| $62.6K | ﹤0.01% |
+10,000
| New | +$58.5K |
|
1061
1stdibs.com
DIBS
$145M
| $62.5K | ﹤0.01% |
+22,712
| New | +$58.8K |
|
1062
Invivyd
IVVD
$180M
| $61.3K | ﹤0.01% |
+85,708
| New | +$60.8K |
|
1063
Voyager Therapeutics
VYGR
$187M
| $60.7K | ﹤0.01% |
+19,504
| New | +$62.9K |
|
1064
Sutro Biopharma
STRO
$379M
| $60.3K | ﹤0.01% |
+8,447
| New | +$69.1K |
|
|
HLVX
1065
DELISTED
HilleVax
HLVX
| $60.2K | ﹤0.01% |
+30,257
| New | +$55.3K |
|
1066
Repay Holdings
RPAY
$315M
| $55.8K | ﹤0.01% |
+11,571
| New | +$52.8K |
|
1067
TScan Therapeutics
TCRX
$51.9M
| $54.9K | ﹤0.01% |
+37,888
| New | +$54.7K |
|
1068
Pyxis Oncology
PYXS
$165M
| $53.5K | ﹤0.01% |
+48,649
| New | +$54.8K |
|
1069
Vera Bradley
VRA
$105M
| $53.5K | ﹤0.01% |
+24,192
| New | +$49.9K |
|
1070
Fractyl Health
GUTS
$123M
| $53.3K | ﹤0.01% |
+32,929
| New | +$53.2K |
|
1071
XBiotech
XBIT
$69.2M
| $52.4K | ﹤0.01% |
+17,629
| New | +$51.3K |
|
1072
Destination XL Group
DXLG
$34.7M
| $51.3K | ﹤0.01% |
+46,240
| New | +$50.6K |
|
1073
Zura Bio
ZURA
$497M
| $51.2K | ﹤0.01% |
+48,750
| New | +$58.3K |
|
1074
GrowGeneration
GRWG
$82.9M
| $51.1K | ﹤0.01% |
+54,662
| New | +$58.3K |
|
1075
RLX Technology
RLX
$2.48B
| $50.6K | ﹤0.01% |
+22,900
| New | +$44.8K |
|
Similar funds
SC
CS
Jain Global's Q2 2025 Portfolio in Review
As of Q2 2025, Jain Global held 1,700 positions worth $12.9B, up 54% from $8.39B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jain Global deployed $3.27B of net new capital in Q2 2025, opening 646 new positions and adding to 290 existing holdings. Its largest new stake was Brown & Brown: 997,801 shares worth $111M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $58.5M trimmed.
- Jain Global's largest Q2 2025 buy was Brown & Brown: 997,801 shares worth $111M.
- Jain Global added most to iShares MSCI Emerging Markets ETF in Q2 2025, an estimated $74.9M increase.
- Jain Global's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $58.5M.
- Jain Global fully exited iShares Core S&P 500 ETF in Q2 2025, selling an estimated $1.3B.
- Jain Global's ten largest holdings make up 34% of its $12.9B portfolio in Q2 2025.
- Jain Global opened 646 new positions and closed 568 in Q2 2025.
- Jain Global's portfolio value rose 54% quarter-over-quarter to $12.9B.
Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.